April 2, 2026 — Omron Healthcare Co. has launched a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF) to evaluate a new model for the early detection ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
-
-
Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston (Feb. 5-7, 2026) that demonstrate the strong safety and efficacy of the company's ...
-
Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage ...
-
Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable way to predict who will develop it or when. Unlike conditions such as coronary ...
April 13, 2026 — Heart failure is common in people who have atrial fibrillation detected during screening, according to ...
April 14, 2026
April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...
April 13, 2026
April 2, 2026 — Omron Healthcare Co. has launched a randomized controlled trial in collaboration with the University of ...
April 03, 2026Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Argá Medtech Reports Clinical Results of First-in-Human BURST-AF Trial of Single-Catheter PFA System
Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...
February 09, 2026
Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further ...
February 09, 2026
Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...
February 06, 2026Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...
February 03, 2026
Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...
January 22, 2026
Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...
January 21, 2026Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023
Dec. 19, 2025 — Johnson & Johnson MedTech has announced its sponsorship of a new data collection platform developed by ...
December 19, 2025
Feature | Atrial Fibrillation | Jeffrey Olgin, M.D.
Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...
September 12, 2025
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...
September 08, 2025Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic ...
September 08, 2025
Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 Y ...
September 04, 2025
July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...
July 09, 2025